Original articleSynthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and α-adrenolytic activity

Add time:08/22/2019    Source:sciencedirect.com

A series of new 1-[3-(4-arylpiperazinyl-1-yl)-2-(N-alkylcarbamoyloxy)propyl]-pyrrolidin-2-one derivatives (4a–12a) were synthesised and tested for their electrocardiographic, antiarrhythmic and antihypertensive activity, as well as for the α1- and α2-adrenoceptor binding affinities. Of the newly synthesised derivatives, 1-{2-(N-2-methylethylcarbamoiloxy)-3-[4-(2-methoxyphenyl)piperazin-1-yl)]propyl}pyrrolidin-2-one dihydrochloride (10a) was the most active in prophylactic antiarrhythmic tests, its ED50 value equalling 2.7 mg kg–1, and the therapeutic index being 75.2; moreover, compound 10a was also found to possess hypotensive activity. A preliminary molecular modelling study suggested that the selected α1-AR antagonist distances and angles between pharmacophoric features, estimated for the tested compounds, were in good agreement with the parameters evaluated for ligands.

We also recommend Trading Suppliers and Manufacturers of (S)-5-(piperidine-1-carbonyl)pyrrolidin-2-one (cas 110958-23-1). Pls Click Website Link as below: cas 110958-23-1 suppliers

Prev:Research ArticlePharmaceutics, Drug Delivery and Pharmaceutical TechnologyA Study of FASORACETAM (cas 110958-19-5)’s Solid State Forms: A Potential Anti-Alzheimer Pharmaceutical
Next:Hydro-de-halogenation and consecutive deprotection of chlorinated N-amido-pyrrolidin-2-ones with Raney-Ni: an effective approach to gabapentin)